pharmacie et médicaments – Impact de la réduction du plafonnement des remises des médicaments génériques

This written question asks about the consequences of lowering the maximum rebates that can be charged for generic medicines. It seeks to understand the potential effects on the pharmaceutical market and drug pricing. The question focuses on the impact on the availability and cost of generic drugs, potentially affecting patients, pharmacies, and pharmaceutical companies.